Successful use of rifampin in a patient with Stevens-Johnson syndrome to rifabutin
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:124 |
|---|---|
| Enthalten in: |
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology - 124(2020), 6 vom: 02. Juni, Seite 624-626 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Yonkof, Jennifer R [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
1W306TDA6S |
|---|
| Anmerkungen: |
Date Completed 06.07.2020 Date Revised 06.07.2020 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.anai.2020.03.001 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM30757556X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM30757556X | ||
| 003 | DE-627 | ||
| 005 | 20231225125849.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.anai.2020.03.001 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1025.xml |
| 035 | |a (DE-627)NLM30757556X | ||
| 035 | |a (NLM)32169513 | ||
| 035 | |a (PII)S1081-1206(20)30144-7 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Yonkof, Jennifer R |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Successful use of rifampin in a patient with Stevens-Johnson syndrome to rifabutin |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 06.07.2020 | ||
| 500 | |a Date Revised 06.07.2020 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a Letter | |
| 650 | 7 | |a Antibiotics, Antitubercular |2 NLM | |
| 650 | 7 | |a Rifabutin |2 NLM | |
| 650 | 7 | |a 1W306TDA6S |2 NLM | |
| 650 | 7 | |a Immunoglobulin E |2 NLM | |
| 650 | 7 | |a 37341-29-0 |2 NLM | |
| 650 | 7 | |a Rifampin |2 NLM | |
| 650 | 7 | |a VJT6J7R4TR |2 NLM | |
| 700 | 1 | |a Tapke, David E |e verfasserin |4 aut | |
| 700 | 1 | |a Fox, Charity C |e verfasserin |4 aut | |
| 700 | 1 | |a Ogbogu, Princess U |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology |d 1995 |g 124(2020), 6 vom: 02. Juni, Seite 624-626 |w (DE-627)NLM075127695 |x 1534-4436 |7 nnns |
| 773 | 1 | 8 | |g volume:124 |g year:2020 |g number:6 |g day:02 |g month:06 |g pages:624-626 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.anai.2020.03.001 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 124 |j 2020 |e 6 |b 02 |c 06 |h 624-626 | ||